Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
416,598,522
-
Total 13F shares
-
73,223,084
-
Share change
-
-15,939,650
-
Total reported value
-
$90,062,636
-
Put/Call ratio
-
71%
-
Price per share
-
$1.23
-
Number of holders
-
121
-
Value change
-
-$13,953,079
-
Number of buys
-
48
-
Number of sells
-
66
Institutional Holders of CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV) as of Q2 2024
As of 30 Jun 2024,
CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV) was held by
121 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
73,223,084 shares.
The largest 10 holders included
VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., PNC Financial Services Group, Inc., GEODE CAPITAL MANAGEMENT, LLC, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Qube Research & Technologies Ltd, CITADEL ADVISORS LLC, and TWO SIGMA INVESTMENTS, LP.
This page lists
122
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.